Home Newsfeeds RAPT Therapeutics Q3 EPS $(0.63), Same YoY

RAPT Therapeutics Q3 EPS $(0.63), Same YoY

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is unchanged from the same period last year.

Global
News

“Agilysys POS Platform Approved For Marriott International Properties In U.S. And Canada”

By Benzinga Newsdesk

May 9, 10:45 AM

https://www.agilysys.com/en/agilysys-pos-platform-approved-for-marriott-international-properties-in-u-s-and-canada/ – Cloud-Native InfoGenesis® Point-of-Sale Platform Approved as Option Across Marriott's

AGYS

Here’s How Much $100 Invested In Synopsys 10 Years Ago Would Be Worth Today

By Benzinga Insights

July 1, 5:03 PM

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 25.9%. Currently, Synopsys has a market capitalization of $46.08 billion.

SNPS